The University of Southampton
University of Southampton Institutional Repository

Incidence, prevalence, and global burden of attention-deficit/hyperactivity disorder from 1990 to 2021 across 204 countries in individuals under age 20: data, with critical appraisal, from the 2021 Global Burden of Disease study

Incidence, prevalence, and global burden of attention-deficit/hyperactivity disorder from 1990 to 2021 across 204 countries in individuals under age 20: data, with critical appraisal, from the 2021 Global Burden of Disease study
Incidence, prevalence, and global burden of attention-deficit/hyperactivity disorder from 1990 to 2021 across 204 countries in individuals under age 20: data, with critical appraisal, from the 2021 Global Burden of Disease study
Importance: estimating the global and national incidence, prevalence, and burden of attention-deficit/hyperactivity disorder (ADHD) in children and young people is relevant for informing public health initiatives.

Objective: to report and discuss the global and national incidence, prevalence, and burden of ADHD in children and young people according to the 2021 Global Burden of Disease Study (GBD) 2021.

Design, setting, and Participants: This was a global population-based study using data from GBD 2021, encompassing 204 countries and territories. The analysis included children and youths under 20 years of age with ADHD.
Exposure: ADHD among children and youths under 20 years of age, evaluated from 1990 to 2021.

Main outcome measures: incidence, prevalence, and disability-adjusted life years (DALYs).

Results: globally in 2021, there were a total of 46,890,733 (95% uncertainty interval [UI]: 32,136,904 to 67,271,064) prevalent cases and 4,111,621 (2,775,203 to 5,954,941) incident cases of ADHD in individuals under 20 years old. ADHD caused a total of 574,979 (294,277 to 977,557) DALYs. The prevalence and incidence rates of ADHD were 1.78% (1.22% to 2.55%) and 0.16% (0.11% to 0.23%), respectively. The DALY rate of ADHD was 21.8 (11.2 to 37.1) per 100,000 population. In 2021, prevalence (5.62%, 95% UI: 4.16% to 7.46%) and incidence (0.49%, 95% UI: 0.34% to 0.66%) were highest in Australia. From 1990 to 2021, the global prevalence and incidence rates decreased by 6% (95% UI: −8.48 to −3.45) and 5.81% (95% UI: −8.21 to −3.04), respectively. Prevalence was consistently higher in males than in females across all GBD regions [males: 2.52% (1.72 to 3.62); females, 0.99% (0.68 to 1.44)]. Prevalence was higher with increasing socio-demographic index (SDI) ([2.88% (95% UI 1.94 to 4.09)] in the highest SDI subgroup).

Conclusions and relevance: the GBD 2021 represent the most comprehensive source for the global prevalence, incidence, and burden of ADHD. These findings can inform policymakers and stakeholders. However, due to potential methodological issues, the GBD data may have underestimated the prevalence, incidence, and burden of ADHD.
1359-4184
5931-5940
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb
Kim, Min Seo
b30793be-87f8-47a9-81c2-ae39bc9a1ea1
Han, Jong Hoon
62e004ec-40da-4c8a-877a-169c8d8f09d6
Oh, Sarah Soyeon
6d01fbf9-5e7b-4a73-a753-eac8d1b528e0
Yon, Dong Keon
1c7386e1-7a78-441c-942e-c9b35a1203cc
Shin, Jae Il
cc12b7c4-5ec5-4903-a6de-9d1cb61dabde
Solmi, Marco
8dc5ef1e-4b0d-4047-a55b-6c4c7a93cf00
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb
Kim, Min Seo
b30793be-87f8-47a9-81c2-ae39bc9a1ea1
Han, Jong Hoon
62e004ec-40da-4c8a-877a-169c8d8f09d6
Oh, Sarah Soyeon
6d01fbf9-5e7b-4a73-a753-eac8d1b528e0
Yon, Dong Keon
1c7386e1-7a78-441c-942e-c9b35a1203cc
Shin, Jae Il
cc12b7c4-5ec5-4903-a6de-9d1cb61dabde
Solmi, Marco
8dc5ef1e-4b0d-4047-a55b-6c4c7a93cf00

Cortese, Samuele, Kim, Min Seo, Han, Jong Hoon, Oh, Sarah Soyeon, Yon, Dong Keon, Shin, Jae Il and Solmi, Marco (2026) Incidence, prevalence, and global burden of attention-deficit/hyperactivity disorder from 1990 to 2021 across 204 countries in individuals under age 20: data, with critical appraisal, from the 2021 Global Burden of Disease study. Molecular Psychiatry, 31 (10), 5931-5940. (doi:10.1038/s41380-026-03683-4).

Record type: Article

Abstract

Importance: estimating the global and national incidence, prevalence, and burden of attention-deficit/hyperactivity disorder (ADHD) in children and young people is relevant for informing public health initiatives.

Objective: to report and discuss the global and national incidence, prevalence, and burden of ADHD in children and young people according to the 2021 Global Burden of Disease Study (GBD) 2021.

Design, setting, and Participants: This was a global population-based study using data from GBD 2021, encompassing 204 countries and territories. The analysis included children and youths under 20 years of age with ADHD.
Exposure: ADHD among children and youths under 20 years of age, evaluated from 1990 to 2021.

Main outcome measures: incidence, prevalence, and disability-adjusted life years (DALYs).

Results: globally in 2021, there were a total of 46,890,733 (95% uncertainty interval [UI]: 32,136,904 to 67,271,064) prevalent cases and 4,111,621 (2,775,203 to 5,954,941) incident cases of ADHD in individuals under 20 years old. ADHD caused a total of 574,979 (294,277 to 977,557) DALYs. The prevalence and incidence rates of ADHD were 1.78% (1.22% to 2.55%) and 0.16% (0.11% to 0.23%), respectively. The DALY rate of ADHD was 21.8 (11.2 to 37.1) per 100,000 population. In 2021, prevalence (5.62%, 95% UI: 4.16% to 7.46%) and incidence (0.49%, 95% UI: 0.34% to 0.66%) were highest in Australia. From 1990 to 2021, the global prevalence and incidence rates decreased by 6% (95% UI: −8.48 to −3.45) and 5.81% (95% UI: −8.21 to −3.04), respectively. Prevalence was consistently higher in males than in females across all GBD regions [males: 2.52% (1.72 to 3.62); females, 0.99% (0.68 to 1.44)]. Prevalence was higher with increasing socio-demographic index (SDI) ([2.88% (95% UI 1.94 to 4.09)] in the highest SDI subgroup).

Conclusions and relevance: the GBD 2021 represent the most comprehensive source for the global prevalence, incidence, and burden of ADHD. These findings can inform policymakers and stakeholders. However, due to potential methodological issues, the GBD data may have underestimated the prevalence, incidence, and burden of ADHD.

Text
Cortese_et_al_MP_2026 - Accepted Manuscript
Available under License Creative Commons Attribution.
Download (906kB)
Text
s41380-026-03683-4 (2) - Version of Record
Available under License Creative Commons Attribution.
Download (2MB)

More information

Accepted/In Press date: 3 June 2026
e-pub ahead of print date: 16 June 2026

Identifiers

Local EPrints ID: 512376
URI: https://eprints.soton.ac.uk/id/eprint/512376
ISSN: 1359-4184
PURE UUID: 3d79ef12-c2e6-4671-9d02-0aa1c44d6314
ORCID for Samuele Cortese: ORCID iD orcid.org/0000-0001-5877-8075

Catalogue record

Date deposited: 26 Jun 2026 16:32
Last modified: 18 Sep 2026 01:54

Export record

Altmetrics

Contributors

Author: Samuele Cortese ORCID iD
Author: Min Seo Kim
Author: Jong Hoon Han
Author: Sarah Soyeon Oh
Author: Dong Keon Yon
Author: Jae Il Shin
Author: Marco Solmi

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of https://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×